Main menu

β-lactamase amplification and porin loss drive progressive β-lactam resistance in recurrent ESBL Enterobacteriaceae bacteremia


Carbapenem resistant Enterobacteriaceae (CRE) are a critical public health issue. Recent studies indicate many CRE lack carbapenemases, but contain extended spectrum β-lactamases (ESBLs). We investigated 16 longitudinal, recurrent cases of extended spectrum B-lactamase (ESBL)-positive Enterobacteriaceae bacteremia to gain insights into mechanisms underlying the emergence of non-carbapenemase producing CRE (non-CP-CRE). Using a combination of short- and long-read sequencing technologies, we identified that non-CP-CRE emerges from an ESBL background through a combination of insertion sequence mediated β-lactamase translocation, subsequent amplification of β-lactamase encoding genes such as blaOXA-1 and blaCTX-M, and porin inactivation. Interestingly, the β-lactamase gene amplification occurred both on plasmids and on the chromosome, including in the middle of porin-encoding genes. Additionally, overexpression of blaOXA-1 increased resistance to the broad-spectrum β-lactam, piperacillin-tazobactam. This analysis shows mechanisms underlying non-CP-CRE emergence and demonstrates that copy number of β-lactamase genes needs to be considered to fully understand antimicrobial resistance amongst key human pathogens.

Authors: William C. Shropshire, Samuel L. Aitken, Reed Pifer, Jiwoong Kim, Micah M. Bhatti, Xiqi Li, Awdhesh Kalia, Jessica Galloway-Peña, Pranoti Sahasrabhojane, Cesar A. Arias, David E. Greenberg, Blake M. Hanson, Samuel A. Shelburne

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag